S Yaallini Sukumaran, Charline Herrscher, Nurulfazlina Edayah Rasol, Muhamad Aqmal Othman, Sook Yee Liew, Nor Hadiani Ismail, Karin Séron, Marc Litaudon, Khalijah Awang, Chaker El Kalamouni, Cécile Apel, Azeana Zahari
{"title":"Targeted Isolation of Antiviral Labdane Diterpenes from the Bark of <i>Neo-uvaria foetida</i> (Annonaceae) using LC-MS/MS-Based Molecular Networking.","authors":"S Yaallini Sukumaran, Charline Herrscher, Nurulfazlina Edayah Rasol, Muhamad Aqmal Othman, Sook Yee Liew, Nor Hadiani Ismail, Karin Séron, Marc Litaudon, Khalijah Awang, Chaker El Kalamouni, Cécile Apel, Azeana Zahari","doi":"10.1021/acs.jnatprod.4c00342","DOIUrl":null,"url":null,"abstract":"<p><p>In the search of new inhibitors for human coronavirus (HCoV), we screened extracts of endemic Annonaceae plants on an assay using a cellular model of Huh-7 cells infected with the human alphacoronavirus HCoV-229E. The EtOAc bark extract of the rare Southeast Asian plant <i>Neo-uvaria foetida</i> exhibited inhibition of HCoV-229E and SARS-CoV-2 viruses with IC<sub>50</sub> values of 3.8 and 7.8 μg/mL, respectively. Using LC-MS/MS and molecular networking analysis guided isolation, we discovered two new labdane-type diterpenoids, 8-<i>epi</i>-acuminolide (<b>1</b>) and foetidalabdane A (<b>4</b>), and three known labdane diterpenoids, acuminolide (<b>2</b>), 17-<i>O</i>-acetylacuminolide (<b>3</b>), and spiroacuminolide (<b>5</b>). A new norlabdane diterpene, 16-foetinorlabdoic acid (<b>6</b>), was also isolated and identified. Excluding compounds <b>5</b> and <b>6</b>, all other metabolites were active against the virus HCoV-229E. Terpenoids <b>1</b> and <b>4</b> presented antiviral activity against SARS-CoV-2 with IC<sub>50</sub> values of 63.3 and 93.5 μM, respectively, indicating lower potency. Additionally, virological assays demonstrated that compounds <b>1</b>, <b>2</b>, and <b>3</b> exert antiviral effects against Zika virus by specifically interfering with the late stage of its infectious cycle with IC<sub>50</sub> values of 76.0, 31.9, and 14.9 μM, respectively.</p>","PeriodicalId":47,"journal":{"name":"Journal of Natural Products ","volume":" ","pages":"1941-1951"},"PeriodicalIF":3.3000,"publicationDate":"2024-08-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Natural Products ","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1021/acs.jnatprod.4c00342","RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/7/19 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0
Abstract
In the search of new inhibitors for human coronavirus (HCoV), we screened extracts of endemic Annonaceae plants on an assay using a cellular model of Huh-7 cells infected with the human alphacoronavirus HCoV-229E. The EtOAc bark extract of the rare Southeast Asian plant Neo-uvaria foetida exhibited inhibition of HCoV-229E and SARS-CoV-2 viruses with IC50 values of 3.8 and 7.8 μg/mL, respectively. Using LC-MS/MS and molecular networking analysis guided isolation, we discovered two new labdane-type diterpenoids, 8-epi-acuminolide (1) and foetidalabdane A (4), and three known labdane diterpenoids, acuminolide (2), 17-O-acetylacuminolide (3), and spiroacuminolide (5). A new norlabdane diterpene, 16-foetinorlabdoic acid (6), was also isolated and identified. Excluding compounds 5 and 6, all other metabolites were active against the virus HCoV-229E. Terpenoids 1 and 4 presented antiviral activity against SARS-CoV-2 with IC50 values of 63.3 and 93.5 μM, respectively, indicating lower potency. Additionally, virological assays demonstrated that compounds 1, 2, and 3 exert antiviral effects against Zika virus by specifically interfering with the late stage of its infectious cycle with IC50 values of 76.0, 31.9, and 14.9 μM, respectively.
期刊介绍:
The Journal of Natural Products invites and publishes papers that make substantial and scholarly contributions to the area of natural products research. Contributions may relate to the chemistry and/or biochemistry of naturally occurring compounds or the biology of living systems from which they are obtained.
Specifically, there may be articles that describe secondary metabolites of microorganisms, including antibiotics and mycotoxins; physiologically active compounds from terrestrial and marine plants and animals; biochemical studies, including biosynthesis and microbiological transformations; fermentation and plant tissue culture; the isolation, structure elucidation, and chemical synthesis of novel compounds from nature; and the pharmacology of compounds of natural origin.
When new compounds are reported, manuscripts describing their biological activity are much preferred.
Specifically, there may be articles that describe secondary metabolites of microorganisms, including antibiotics and mycotoxins; physiologically active compounds from terrestrial and marine plants and animals; biochemical studies, including biosynthesis and microbiological transformations; fermentation and plant tissue culture; the isolation, structure elucidation, and chemical synthesis of novel compounds from nature; and the pharmacology of compounds of natural origin.